Get the latest tech news
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are already huge inequities in access and uptake.
Carina Marquez, an associate professor of medicine at the University of California, San Francisco, is a big believer in prevention. Preliminary data she collected last year from 300 survey participants found many were interested in the RSV shot, but that there was also a “big call for more information.” “As this is a new vaccine for our elders, we need to understand the most effective approaches to facilitate uptake,” says Diane Havlir, chief of the Zuckerberg San Francisco General Hospital’s HIV and infectious diseases division, who is assisting with the study.
Or read this on Wired
